Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Venture Life ( (GB:VLG) ) has shared an update.
Venture Life Group PLC reported a trading update for the fiscal year 2024, highlighting a 1% increase in revenues to approximately £51.8 million. The company integrated Health and Her Limited, contributing to the VLG Brands’ revenue growth of 11% over the year. Despite a slight decline in Customer Brands revenues, the second half of the year saw strong gross margins and stable cash flow generation. The acquisition is expected to enhance VLG’s presence in the UK market and improve revenue and profitability in 2025, supported by increased marketing investment and new business initiatives.
More about Venture Life
Venture Life is an international consumer self-care company focusing on developing, manufacturing, and commercializing products for the global self-care market. It operates in the UK, Italy, The Netherlands, and Sweden, offering a range of products in women’s intimate healthcare, ENT care, energy and glucose management, oncology support, oral care, and dermo-cosmetics. These products are typically recommended by pharmacists or healthcare practitioners and are available primarily through pharmacies and grocery multiples.
YTD Price Performance: -12.10%
Average Trading Volume: 184,830
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £44.18M
For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.
